Showing results (291-300 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|October 11, 2021
Predictors of adherence and persistence to disease-modifying therapies in Multiple SclerosisGisela Zanga, Estefania Drzewiscki, Paula Tagliani, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysisMingxia Li, Fangfang Ge, Rongjing Guo, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patientsKimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Radiomics-based prediction of hemorrhage expansion among patients with thrombolysis/thrombectomy related-hemorrhagic transformation using machine learningJunfeng Liu, Wendan Tao, Zhetao Wang, et al.
Therapeutic Advances in Neurological Disorders|October 21, 2021
Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tabletsRalf Gold, Gerd Fätkenheuer, Hans-Peter Hartung, et al.
Therapeutic Advances in Neurological Disorders|January 24, 2022
MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case reportJordi Kühne Escolà, Cornelius Deuschl, Andreas Junker, et al.
Therapeutic Advances in Neurological Disorders|July 11, 2022
Association of compromised cerebral perfusion with lenticulostriate artery impairments in the subacute phase of branch atheromatous diseaseShuai Jiang, Jing-Yu Cui, Yu-Ying Yan, et al.
Therapeutic Advances in Neurological Disorders|March 3, 2022
Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literatureJordi Sarto, Berta Caballol, Joan Berenguer, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Therapeutic Advances in Neurological Disorders|September 1, 2023
Network topology in brain tumor patients with and without structural epilepsy: a prospective MEG studyBarbara Ladisich, Stefan Rampp, Eugen Trinka, et al.
Pageof 108